Written answers

Tuesday, 28 June 2022

Department of Health

Medicinal Products

Photo of Joe O'BrienJoe O'Brien (Dublin Fingal, Green Party)
Link to this: Individually | In context | Oireachtas source

755. To ask the Minister for Health the status of talks between the HSE and an organisation (details supplied) in relation to the life-changing cystic fibrosis drug therapy kaftrio to make this drug therapy available to 35 children with cystic fibrosis aged between six and eleven years; and if he will make a statement on the matter. [33672/22]

Photo of James LawlessJames Lawless (Kildare North, Fianna Fail)
Link to this: Individually | In context | Oireachtas source

868. To ask the Minister for Health if there are plans to provide children with cystic fibrosis with the drug kaftrio; if not, the reasons for not providing this drug; if there are any plans in the future to provide this drug; and if he will make a statement on the matter. [34274/22]

Photo of Alan FarrellAlan Farrell (Dublin Fingal, Fine Gael)
Link to this: Individually | In context | Oireachtas source

882. To ask the Minister for Health if the HSE is considering funding kaftrio, which is used to treat cystic fibrosis patients; and if he will make a statement on the matter. [34338/22]

Photo of Stephen DonnellyStephen Donnelly (Wicklow, Fianna Fail)
Link to this: Individually | In context | Oireachtas source

I propose to take Questions Nos. 755, 868 and 882 together.

Under the Health (Pricing and Supply of Medical Goods) Act 2013, the HSE has statutory responsibility for the administration of the community drug schemes; therefore, the matter has been referred to the HSE for attention and direct reply to the Deputy.

Comments

No comments

Log in or join to post a public comment.